DOCSLIB.ORG

Invited Review Roles of Integrins in Fibronectin Matrix Assembly

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Invited Review Roles of Integrins in Fibronectin Matrix Assembly Histol Histopathol (1997) 12 : 233-240 Histology and 001: 10.14670/HH-12.233 Histopathology http://www.hh.um.es From Cell Biology to Tissue Engineering Invited Review Roles of integrins in fibronectin matrix assembly C.Wu Department of Biochemistry and Molecular Biology, Samuel C. Johnson Medical Research Center, Mayo Clinic Scottsdale, 13400 E. Shea Blvd, Scottsdale, USA Summary. F ibro nectin (Fn ) ma trix assem b ly is a in man). Only with wounding or during he mostasis is Fn dynamic cellular process in whi ch the soluble dimeri c Fn expressed locall y and deposited into extracellular matrix. molecules are assembled into insoluble, d isul fide bond Cell s not onl y respond to signals fro m Fn matrix but also stabil ized fi brillar polymeric matrix. Fn matrix assembly actively partic ipate in the fo rmati on of a Fn ma tri x. requires s pec ific Fn binding integrin s . Severa l Fn Recent studies suggest that specific cell surface Fn binding integrins that are capable of mediating Fn matrix binding integrins play important roles in initiation and assembly have been ident ified . They include a5B I , regulati on of fibronectin matrix assembly. In this review, a llbB3 and avB3 integrins. Cell s regula te the matrix I will provide a brief overview of recent advances in our assembly process not onl y by controlling cell surface unde rsta nd ing of the ro les of integrins in Fn matri x expression level of the Fn binding integrins but also by assembly. mo dul a ting F n binding a nd cy tos ke le to n b inding acti vit ies of the integrins. A major cha lle nge of future Fn domains involved in Fn matrix assembly studies is to delineate the signal transducti on pathway that regulates Fn matrix assembly. Fns a re modular, multido ma in g lycopro te ins of approx imately 500,000 daltons consisting of repeating Key words: Integrins, Fibronectins, Extracellular matri x homologies of three types (Type I, II and III ) (Fig. I) assembly, Signal transducti on (Hynes, 1990). Each F n molecule contains two similar di sul fide bonded subunits with d iffe re nces created by RNA splic ing, a nd by g lycosy lation a nd othe r post­ Introduction translati onal modificati ons (Hynes, 1990). The disul fide­ bonded dimer structure of Fn is c ri tical fo r Fn matri x Fibronectins (Fns) are cell adhesive g lycoproteins assembly (Schwarzbauer, 199 1; Ichihara et al. , 1995). In tha t pl ay c riti cal ro les in m a ny bi o log ical a nd addition , the first five type I re peats (29 kDa Matri x pathological processes including embryogenesis, wound Assembly Site, Fig . I ) (McKeown-Longo and Mosher, healing, metastasis, fibrosis a nd thro mbosis (Hynes, 1985; Quade and McDonald , 1988; Schwarzbauer, 199 1; 1990). During organogenesis, Fns are major constituents Sott il e a nd Wiley, 1994), the first ty pe III re peat of the extracellular matrix. Inactivation of the mouse Fn (Homophilic Interacti ve Site , Fig. I) (Chernousov et al. , gene caused early e mbryonic lethality (George e t al. , 199 1; Mori a and Ruoslahti , 1992), and the arg-gly-asp 1993) , de mo ns trating tha t Fn is ind is pe nsable for (RGD) containing integrin binding domain are important verte bra te e mbryogenesis. F n matrix assembly is a fo r Fn matrix assembly (McDonald, 1988; McDonald et dynamic cellular process in which the soluble dimeric Fn al. , 1987; Mosher et al. , 1992; Hocking et al. , 1996). The molecules are assembled into in soluble , disul fi de bond first five type I re peats of Fn that apparently fold to form stabili zed fibrillar polyme ri c matri x (McDonald , 1988; a high affinity binding site fo r specific components on Mosher et al. , 1992). Matri x Fn promotes cell adhesion, the surface of matrix fo rming cell s (Limper et al. , 199 1; mi grati on and di ffe re ntiati on , and thus is the primary Sottile et al. , 199 1; Moon et al. , 1994). Fn fragments that func ti onal form o f the protein. The assembly o f a Fn inc lude thi s d o m a in inhibit m a tri x forma tio n b y matrix is both temporall y and spati all y regulated in vivo. f ibro blasts ( Mc Keow n- Lo ngo a nd M osher, 1985; For example, in adult mammals, most Fn is synthesized McDonald et al. , 1987 ; Quade and McDonald , 1988), by the li ver a nd exists primaril y as a soluble pl asma resulting in a specific phenotype characteri zed by short prote in present at hi gh concentration (about 300 mg/ml stitches of cell surface Fn associated with a5BI integrin receptors. The first five type I repeats of Fn are also Offprint requests to: Chuanyue Wu , Ph .D., Department of Cell Biology, required fo r de novo assembly of recombinant Fns into Volker Hall, 1670 University Boulevard, The University of Alabama at the extracellular matrix (Schwarzbauer, 199 1; Sottile and Birm ingham. Birmingham , AL 35294, USA Wiley, 1994). Antibodies recogni zing the first type III 234 /ntegrins in matrix assembly repeat inhibit Fn binding and matrix assembly by Fn-binding integrins fibroblasts (Chernousov et a!., 1991). However, recombinant Fn lacking the first type III repeat can be Integrins are aB heterodimeric transmembrane assembled into the matrix (Schwarzbauer, 1991; glycoproteins that interact with extracellular (or other Ichihara-Tanaka et aI., 1992), suggesting that this site is cell surface) molecules and cytoplasmic molecules not absolutely required for Fn matrix assembly. The first including cytoskeletal and catalytic signaling proteins five type I repeats bind to the first several type III (Ruoslahti, 1988; Hynes, 1992; Schwartz et aI., 1995). repeats and it has been proposed that this interaction Integrins mediate cell-cell and cell-extracellular matrix may be involved in regulation of Fn-Fn interactions interactions and have been implicated in many biological (Aguirre et a!., 1994). Indeed, a specific peptide and pathological processes including embryogenesis, sequence derived from the first type m repeat induces wound healing, inflammation and cancer. Several disulfide crosslinking of Fn into high molecular weight integrins, including aSB1, a4BI , avBI , aIIbB3 and multimers in vitro (Moria and Ruoslahti, 1992; Moria et avB3, bind Fns. Most of the Fn-binding integrins (aSB1 , a!., 1994) . However, attempts to demonstrate the avBI, alIbB3 and avB3) recognize the RGD containing presence of a Fn fragment equivalent to this peptide cell binding domain. In addition to the common RGD under physiological condition have been unsuccessful sequence, distinctive sequences (synergy regions) (Moria et aI., 1994). In addition, it has been shown that located amino-terminal to the RGD sequence also the heat-denatured first type III module, but not the contribute to the binding of Fn to aSB1 integrin (Aota et native form of the module, binds to the 70 kDa amino aI., 1991, 1994) and alIbB3 integrin (Bowditch et a I. , terminal fragment of Fn (Hocking et aI. , 1994). These 1991 , 1994). In contrast to aSBI, avBI, alIbB3 and results suggest that during Fn matrix assembly in avB3, a4B1 integrin recognizes the CS I (or V2S) site cultured cells and in vivo, one or more earlier events are within the alternatively spliced IIICS (or V) region of Fn required to unmask putative homophilic binding sites on (Fig. 1) (Wayner et aI., 1989; Guan and Hynes, 1990; Fn. One of the earliest events in Fn matrix assembly by Mould et aI. , 1990). cu ltured cells appears to be the binding of Fn to cell The ligand binding affinity of a given integrin may surface mediated by interactions between the RGD vary depending on its cellular environment. For containing cell binding domain of Fn and specific Fn example, aSBI integrin binds Fn with high affinity binding integrins (Wu et a!., 1993, 1995c, 1996; (Kd~O.1 p.M) in CHO cells but it binds Fn with low Hocking et aI. , 1996). Antibodies to the RGD containing affinity (Kd >1 pM) in human KS62 erythroleukemia cell binding domain and Fn fragments containing the cell cells (O'Toole et aI. , 1994). The effect of cellular binding domain inhibit Fn matrix assembly by environment on integrin ligand binding affinity is fibroblasts, resulting in fewer fibrils that are of normal dependent on specific types of integrins, as another Fn­ length, consistent with a role for this site in initiation of binding integrin, alIbB3, has low affinity ligand binding Fn matrix assembly in these cells (McDonald et aI., in CHO cells (O'Toole et aI., 1994). This is similar to 1987; Roman et aI., 1989). aIIbB3 integrin on resting circulation platelets, which Homophilic Interactive Site cao- SS EDlIl-8 Illes S S or V -aac.l..l..fnL Heparin I Collagen Binding Heparin II ~ Domain o Type I (45 aa) Homologous o Type II (60 aa) Repeats Type III (90 aa) Fig. 1. Fn o domain structure. A Variably Spliced U 235 Integrins in matrix assembly also has a low affinity binding state. The ligand binding Integrin-cytoplasmic molecule interactions affinity of integrins can be controlled from within the cells ("inside-ollt signaling" ) (Ginsberg et aI., 1992; Tntegrins are capable of interacting with various Hynes, 1992; Schwartz et aI., 1995). Recent studies have cytoskeletal and catalytic signaling proteins molecules demonstrated that the integrin cytoplasmic domains (Fig. 2). The major cytoskeleton-binding sites have been mediate inside-out signal transduction. One of the best located to the 13 cytoplasmic domain of integrins (Sastry studied integrins in term of inside-out signal and Horwitz, 1993).
Load more

Recommended publications
  • PAPC Couples the Segmentation Clock to Somite Morphogenesis by Regulating N-Cadherin-Dependent Adhesion
    © 2017. Published by The Company of Biologists Ltd | Development (2017) 144, 664-676 doi:10.1242/dev.143974 RESEARCH ARTICLE PAPC couples the segmentation clock to somite morphogenesis by regulating N-cadherin-dependent adhesion Jérome Chal1,2,3,4,5,*, Charlenè Guillot3,4,* and Olivier Pourquié1,2,3,4,5,6,7,‡ ABSTRACT specific level of the PSM called the determination front. The Vertebrate segmentation is characterized by the periodic formation of determination front is defined as a signaling threshold epithelial somites from the mesenchymal presomitic mesoderm implemented by posterior gradients of Wnt and FGF (Aulehla (PSM). How the rhythmic signaling pulse delivered by the et al., 2003; Diez del Corral and Storey, 2004; Dubrulle et al., segmentation clock is translated into the periodic morphogenesis of 2001; Hubaud and Pourquie, 2014; Sawada et al., 2001). Cells of somites remains poorly understood. Here, we focused on the role of the posterior PSM exhibit mesenchymal characteristics and paraxial protocadherin (PAPC/Pcdh8) in this process. We showed express Snail-related transcription factors (Dale et al., 2006; that in chicken and mouse embryos, PAPC expression is tightly Nieto, 2002). In the anterior PSM, cells downregulate snail/slug regulated by the clock and wavefront system in the posterior PSM. We expression and upregulate epithelialization-promoting factors such observed that PAPC exhibits a striking complementary pattern to N- as paraxis (Barnes et al., 1997; Sosic et al., 1997). This molecular cadherin (CDH2), marking the interface of the future somite boundary transition correlates with the anterior PSM cells progressively in the anterior PSM. Gain and loss of function of PAPC in chicken acquiring epithelial characteristics (Duband et al., 1987; Martins embryos disrupted somite segmentation by altering the CDH2- et al., 2009).
    [Show full text]
  • Induction of Beta3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf-MEK-Extracellular Signal- Regulated Kinase Signaling Pathway
    Thomas Jefferson University Jefferson Digital Commons Cardeza Foundation for Hematologic Research Sidney Kimmel Medical College 5-2001 Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal- regulated kinase signaling pathway. Douglas Woods Cancer Research Institute and Department of Cellular and Molecular Pharmacology Holly Cherwinski DNAX Research Institute Eleni Venetsanakos Cancer Research Institute and Department of Cellular and Molecular Pharmacology Arun Bhat FCancerollow thisResear andch additional Institute worksand Depar at: https:/tment/jdc.jeff of Cellularerson.edu/car and Moleculardeza_foundation Pharmacology Stephan Part of Gysin the Hemat ology Commons LetCancer us Resear knowch Institute how and Deparaccesstment of t Cellularo this and document Molecular Pharmacology benefits ouy RecommendedSee next page for Citation additional authors Woods, Douglas; Cherwinski, Holly; Venetsanakos, Eleni; Bhat, Arun; Gysin, Stephan; Humbert, Martine; Bray, Paul F.; Saylor, Vicki L.; and McMahon, Martin, "Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway." (2001). Cardeza Foundation for Hematologic Research. Paper 24. https://jdc.jefferson.edu/cardeza_foundation/24 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Cardeza Foundation for Hematologic Research by an authorized administrator of the Jefferson Digital Commons.
    [Show full text]
  • Bilirubin Modulates Leukocyte Recruitment to Sites of Inflammation
    Bilirubin modulates leukocyte recruitment to sites of inflammation A dissertation presented by Megan Elizabeth Vogel B.S., Ohio University 2011 To The Graduate School of the University of Cincinnati in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Internal Medicine, Division of Digestive Diseases of the College of Medicine March 2017 Committee Chair: Stephen D. Zucker, M.D. Abstract Background: Bilirubin is the principal end-product of heme catabolism. While generally thought to be little more than a metabolic by-product, there is accumulating epidemiological evidence that higher serum bilirubin levels are associated with a lower incidence of inflammatory disorders such as inflammatory bowel and cardiovascular disease. However, the mechanism(s) by which bilirubin may exert an anti-inflammatory effect remains poorly understood. The transendothelial migration of immune cells to sites of inflammation is a highly- ordered, multi-step process that is initiated when endothelial cells become activated to express adhesion molecules, including Vascular Cell Adhesion Molecule 1 (VCAM-1) and Intercellular Adhesion Molecule 1 (ICAM-1), on their luminal surface. The specific binding of leukocyte integrins to VCAM-1 and/or ICAM-1 triggers endothelial signaling cascades that result in the intracellular generation of superoxide and hydrogen peroxide. These reactive oxygen species (ROS) induce reorganization of the actin cytoskeleton, promoting leukocyte transmigration. There are many disease states in which VCAM-1 and ICAM-1 are believed to play an essential pathogenic role in mediating leukocyte trafficking. As bilirubin is a potent, chain-breaking antioxidant, our central hypothesis is that it exerts an anti-inflammatory effect by disrupting adhesion molecule-mediated leukocyte migration through the scavenging of ROS signaling intermediaries.
    [Show full text]
  • Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling
    Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling This information is current as Yoko K. Takada, Jessica Yu, Michiko Shimoda and of October 2, 2021. Yoshikazu Takada J Immunol published online 22 July 2019 http://www.jimmunol.org/content/early/2019/07/19/jimmun ol.1801630 Downloaded from Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision http://www.jimmunol.org/ • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on October 2, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 22, 2019, doi:10.4049/jimmunol.1801630 The Journal of Immunology Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling Yoko K. Takada,*,† Jessica Yu,* Michiko Shimoda,* and Yoshikazu Takada*,† CD40L plays a major role in immune response and is a major therapeutic target for inflammation. Integrin a5b1 and CD40 simultaneously bind to CD40L. It is unclear if a5b1 and CD40 work together in CD40/CD40L signaling or how a5b1 binds to CD40L.
    [Show full text]
  • Kinetic Properties of Collagen Receptors on Human Keratinocytes 2337
    Journal of Cell Science 112, 2335-2345 (1999) 2335 Printed in Great Britain © The Company of Biologists Limited 1999 JCS9937 Integrin α and β subunit contribution to the kinetic properties of α2β1 collagen receptors on human keratinocytes analyzed under hydrodynamic conditions Bénédicte Masson-Gadais, Anne Pierres, Anne-Marie Benoliel, Pierre Bongrand* and Jean-Claude Lissitzky Laboratoire d’Immunologie, INSERM U 387, Hôpital de Sainte-Marguerite, BP 29, 13274 Marseille Cedex 09, France *Author for correspondence (e-mail: [email protected]) Accepted 10 May; published on WWW 24 June 1999 SUMMARY The adhesion of keratinocytes to type I collagen or with ligand recognition and also with the ligand-β1 chain laminin 5 was studied in a laminar flow chamber. These interactions responsible for bond stabilization. The latter experiments provided an insight into the binding kinetics hypothesis was supported by the finding that the partial of integrins in their natural environment and the effects of alteration of α2 chain function by inhibiting antibodies was monoclonal antibodies specific for α and β chains. Cells corrected by anti-β1 chain antibody TS2/16. These results driven by a force too low to alter the natural lifetime of a could not be ascribed to allosteric changes of the functional single bond displayed multiple arrests. Studying the region of β1 integrin subunits regulated by TS2/16 since frequency and duration of these arrests yielded fairly direct there was no competition between the binding of TS2/16 information on the rate of bond formation (on-rate) and and anti-α2 chain antibodies. dissociation (off-rate). Off-rate values obtained on collagen Interpreted within the framework of current concepts of or laminin 5 (0.06 seconds−1) were tenfold lower than values integrin-ligand binding topology, these data suggest that determined on selectins.
    [Show full text]
  • BD Pharmingen™ PE Rat Anti-Human Integrin Β7
    BD Pharmingen™ Technical Data Sheet PE Rat Anti-Human Integrin β7 Product Information Material Number: 555945 Size: 100 tests Vol. per Test: 20 µl Clone: FIB504 Isotype: Rat (SD) IgG2a, κ Reactivity: QC Testing: Human Workshop: VI A024, VI 6T-101 Storage Buffer: Aqueous buffered solution containing BSA and ≤0.09% sodium azide. Description FIB504 reacts with mouse integrin β7 subunit (130 kD) but also cross reacts with human integrin β7. Integrin β7 associates with α4 (CD49d) expressed on subsets of lymphocytes and thymus. It also associates with αIEL (CD103) expressed on T cells adjacent to mucosal epithelium and intraepithelial lymphocytes. Integrin β7 plays an important role in the adhesion of leukocytes to endothelial cells promoting the transmigration of leukocytes to extravascular spaces during the inflammatory response. Profile of peripheral blood lymphocytes analyzed on a FACScan (BDIS, San Jose, CA) Preparation and Storage The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed by gel filtration chromatography. Store undiluted at 4° C and protected from prolonged exposure to light. Do not freeze. Application Notes Application Flow cytometry Routinely Tested Suggested Companion Products Catalog Number Name Size Clone 555844 PE Rat IgG2a, κ Isotype Control 100 tests R35-95 555945 Rev. 3 Page 1 of 2 Product Notices 1. This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 X 10e6 cells in a 100-µl experimental sample (a test). 2.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Integrin Alpha 2 Antibody
    Product Datasheet Integrin alpha 2 Antibody Catalog No: #49071 Package Size: #49071-1 50ul #49071-2 100ul Orders: [email protected] Support: [email protected] Description Product Name Integrin alpha 2 Antibody Host Species Rabbit Clonality Monoclonal Clone No. SN0752 Purification ProA affinity purified Applications WB, ICC/IF, IHC, IP, FC Species Reactivity Hu, Ms, Rt Immunogen Description recombinant protein Other Names BR antibody CD 49b antibody CD49 antigen like family member B antibody CD49 antigen-like family member B antibody CD49b antibody CD49b antigen antibody Collagen receptor antibody DX5 antibody Glycoprotein Ia deficiency included antibody GP Ia antibody GP Ia deficiency, included antibody GPIa antibody HPA 5 included antibody HPA5 included antibody Human platelet alloantigen system 5 antibody Integrin alpha 2 antibody Integrin alpha-2 antibody Integrin, alpha 2 (CD49B alpha 2 subunit of VLA 2 receptor) antibody ITA2_HUMAN antibody ITGA2 antibody Platelet alloantigen Br(a), included antibody Platelet antigen Br antibody Platelet glycoprotein GPIa antibody Platelet glycoprotein Ia antibody Platelet glycoprotein Ia/IIa antibody Platelet membrane glycoprotein Ia antibody Platelet receptor for collagen, deficiency of, included antibody Very late activation protein 2 receptor alpha 2 subunit antibody VLA 2 alpha chain antibody VLA 2 antibody VLA 2 subunit alpha antibody VLA-2 subunit alpha antibody VLA2 antibody VLA2 receptor alpha 2 subunit antibody VLAA2 antibody Accession No. Swiss-Prot#:P17301 Calculated MW 150 kDa Formulation 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. Storage Store at -20°C Application Details WB: 1:1,000-5,000 IHC: 1:50-1:200 ICC: 1:100-1:500 FC: 1:50-1:100 Images Address: 8400 Baltimore Ave., Suite 302, College Park, MD 20740, USA http://www.sabbiotech.com 1 Western blot analysis of ITGA2 on A431 cells lysates using anti-ITGA2 antibody at 1/1,000 dilution.
    [Show full text]
  • Integrins: Roles in Cancer Development and As Treatment Targets
    British Journal of Cancer (2004) 90, 561 – 565 & 2004 Cancer Research UK All rights reserved 0007 – 0920/04 $25.00 www.bjcancer.com Minireview Integrins: roles in cancer development and as treatment targets 1 ,1,2 H Jin and J Varner* 1John and Rebecca Moores Comprehensive Cancer Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0912, USA; 2Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0912, USA The integrin family of cell adhesion proteins promotes the attachment and migration of cells on the surrounding extracellular matrix (ECM). Through signals transduced upon integrin ligation by ECM proteins or immunoglobulin superfamily molecules, this family of proteins plays key roles in regulating tumour growth and metastasis as well as tumour angiogenesis. Several integrins play key roles in promoting tumour angiogenesis and tumour metastasis. Antagonists of several integrins (a5b1, avb3 and avb5) are now under evaluation in clinical trials to determine their potential as therapeutics for cancer and other diseases. British Journal of Cancer (2004) 90, 561 – 565. doi:10.1038/sj.bjc.6601576 www.bjcancer.com & 2004 Cancer Research UK Keywords: angiogenesis; metastasis; apoptosis; integrin a5b1; integrin avb3 During the last 10 years, novel insights into the mechanisms sequences (e.g., integrin a4b1 recognises EILDV and REDV in that regulate cell survival as well as cell migration and invasion alternatively spliced CS-1 fibronectin). Inhibitors of integrin have led to the development of novel integrin-based therapeutics function include function-blocking monoclonal antibodies, pep- for the treatment of cancer. Several integrins play important tide antagonists and small molecule peptide mimetics matrix roles in promoting cell proliferation, migration and survival (reviewed in Hynes, 1992; Cheresh, 1993).
    [Show full text]
  • Cell Adhesion and Angiogenesis
    Cell adhesion and angiogenesis. J Bischoff J Clin Invest. 1997;99(3):373-376. https://doi.org/10.1172/JCI119168. Perspective Find the latest version: https://jci.me/119168/pdf Perspectives Series: Cell Adhesion in Vascular Biology Cell Adhesion and Angiogenesis Joyce Bischoff Department of Surgery, Children’s Hospital and Harvard Medical School, Children’s Hospital, Boston, Massachusetts 02115 Introduction and postcapillary venules (3). Thus, the formation of a new mi- Angiogenesis is the growth of new capillary blood vessels from crovessel requires a number of interactions that must be coor- preexisting capillaries and postcapillary venules. This process dinated in a spatially and temporally specified manner. These is critical for normal growth and development and in protec- adhesion events are likely mediated by endothelial cell adhe- tive responses such as wound healing and inflammation. In sion molecules and ECM molecules that provide instructions healthy adults, angiogenesis does not normally occur except in to the endothelial cells as they migrate into the perivascular certain phases of the female reproductive cycle. However, ab- space and assemble into new vessels with surrounding peri- errant angiogenesis can occur in a variety of pathologic set- cytes. tings. These include the neovascularization of solid tumors, the Cell adhesion and endothelial cell growth growth of vessels into the retina in diabetic retinopathy, and the unwanted vessel growth in chronic inflammatory diseases. Adhesion of endothelial cells to ECM and attainment of an The hypothesis that angiogenic diseases, in particular tumor appropriate cellular shape has been known for many years to growth and metastases, may be alleviated by inhibiting the an- be crucial for endothelial cell growth, differentiation, and sur- giogenic responses (1) has prompted many to investigate the vival.
    [Show full text]
  • CD Markers Are Routinely Used for the Immunophenotyping of Cells
    ptglab.com 1 CD MARKER ANTIBODIES www.ptglab.com Introduction The cluster of differentiation (abbreviated as CD) is a protocol used for the identification and investigation of cell surface molecules. So-called CD markers are routinely used for the immunophenotyping of cells. Despite this use, they are not limited to roles in the immune system and perform a variety of roles in cell differentiation, adhesion, migration, blood clotting, gamete fertilization, amino acid transport and apoptosis, among many others. As such, Proteintech’s mini catalog featuring its antibodies targeting CD markers is applicable to a wide range of research disciplines. PRODUCT FOCUS PECAM1 Platelet endothelial cell adhesion of blood vessels – making up a large portion molecule-1 (PECAM1), also known as cluster of its intracellular junctions. PECAM-1 is also CD Number of differentiation 31 (CD31), is a member of present on the surface of hematopoietic the immunoglobulin gene superfamily of cell cells and immune cells including platelets, CD31 adhesion molecules. It is highly expressed monocytes, neutrophils, natural killer cells, on the surface of the endothelium – the thin megakaryocytes and some types of T-cell. Catalog Number layer of endothelial cells lining the interior 11256-1-AP Type Rabbit Polyclonal Applications ELISA, FC, IF, IHC, IP, WB 16 Publications Immunohistochemical of paraffin-embedded Figure 1: Immunofluorescence staining human hepatocirrhosis using PECAM1, CD31 of PECAM1 (11256-1-AP), Alexa 488 goat antibody (11265-1-AP) at a dilution of 1:50 anti-rabbit (green), and smooth muscle KD/KO Validated (40x objective). alpha-actin (red), courtesy of Nicola Smart. PECAM1: Customer Testimonial Nicola Smart, a cardiovascular researcher “As you can see [the immunostaining] is and a group leader at the University of extremely clean and specific [and] displays Oxford, has said of the PECAM1 antibody strong intercellular junction expression, (11265-1-AP) that it “worked beautifully as expected for a cell adhesion molecule.” on every occasion I’ve tried it.” Proteintech thanks Dr.
    [Show full text]
  • Integrin Α2β1 in Nonactivated Conformation Can Induce Focal
    www.nature.com/scientificreports OPEN Integrin α2β1 in nonactivated conformation can induce focal adhesion kinase signaling Received: 17 February 2017 Maria Salmela1, Johanna Jokinen1,2, Silja Tiitta1, Pekka Rappu1, R. Holland Cheng 2 & Jyrki Accepted: 2 May 2017 Heino1 Published: xx xx xxxx Conformational activation of integrins is generally required for ligand binding and cellular signalling. However, we have previously reported that the nonactivated conformation of α2β1 integrin can also bind to large ligands, such as human echovirus 1. In this study, we show that the interaction between the nonactivated integrin and a ligand resulted in the activation of focal adhesion kinase (FAK) in a protein kinase C dependent manner. A loss-of-function mutation, α2E336A, in the α2-integrin did not prevent the activation of FAK, nor did EDTA-mediated inactivation of the integrin. Full FAK activation was observed, since phosphorylation was not only confirmed in residue Y397, but also in residues Y576/7. Furthermore, initiation of downstream signaling by paxillin phosphorylation in residue Y118 was evident, even though this activation was transient by nature, probably due to the lack of talin involvement in FAK activation and the absence of vinculin in the adhesion complexes formed by the nonactivated integrins. Altogether these results indicate that the nonactivated integrins can induce cellular signaling, but the outcome of the signaling differs from conventional integrin signaling. The well-established model of integrin function stresses the importance of the conformational change from a nonactivated, bent conformation to an active, extended state prior to ligand binding and outside-in signaling1. Despite the fact that the conformational activation of integrins is often required for ligand binding, nonactivated integrins may have specific biological functions as well.
    [Show full text]